DECEMBER 23, 2019

Older With IBD: Safety and Efficacy of Combination Therapy

image
Kian Keyashian, MD

Kian Keyashian, MD, a clinical assistant professor of medicine in the Division of Gastroenterology and Hepatology at Stanford University in Redwood City, Calif., discusses the significance of one of the few publications examining the safety and efficacy of combination treatment with an immunomodulator and biologic therapy in older patients with Crohn’s disease.

Study

Singh S Stitt LW, Zou G, et al. Early combined immunosuppression may be effective and safe in older